Abstract
Homozygous or compound heterozygous mutations in the GDAP1 gene cause Charcot–Marie–Tooth (CMT4A) that are consistent with an autosomal recessive mode of inheritance. The case reported in this study is clinically and genetically diagnosed with recessive CMT4A that is caused by a compound novel heterozygous GDAP1 mutation. The genomic DNA of the proband with the clinical diagnosis of CMT was screened for GDAP1 mutations using a targeted next-generation sequencing (NGS) gene-panel that comprised of 27 CMT genes. Two novel compound heterozygous amino acid changing variants were identified in the GDAP1 gene, c.246C>G p.His82Gln in exon 2 and c.614T>G p.Leu205Trp in exon 5. The two amino acid changing variants were not previously reported in the 1000 Genome, Mutation Taster and gnomAD. Our findings expand the phenotypic characterization of the two novel heterozygous mutations associated with CMT4A (AR-CMT1A) and add to the repertoire of GDAP1 mutations related to autosomal recessive CMT in Chinese populations.
Similar content being viewed by others
References
Ben Othmane K., Hentati F., Lennon F., Ben Hamida C., Blel S., Roses A. D. et al. 1993 Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum. Mol. Genet. 2, 1625–1628.
Birouk N., Azzedine H., Dubourg O., Muriel M. P., Benomar A., Hamadouche T. et al. 2003 Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene. Arch. Neurol. 60, 598–604.
Braathen G. J. 2012 Genetic epidemiology of Charcot-Marie-Tooth disease. Acta. Neurol. Scand. Suppl. 193.
Barneo-Muñoz M., Juárez P., Civera-Tregón A., Yndriago L., Pla-Martin D., Zenker J. et al. 2015 Lack of GDAP1 induces neuronal calcium and mitochondrial defects in a knockout mouse model of charcot-marie-tooth neuropathy. PLoS Genet. 11, e1005115.
Cuesta A., Pedrola L., Sevilla T., García-Planells J., Chumillas M. J., Mayordomo F. et al. 2002 The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat. Genet. 30, 22–25.
Garcia-Sobrino T., Blanco-Arias P., Palau F., Espinos C., Ramirez L., Estela A. et al. 2017 Phenotypical features of a new dominant GDAP1 pathogenic variant (p. R226del) in axonal Charcot-Marie-Tooth disease. Neuromuscul. Disord. 27, 667–672.
Henikoff S. and Henikoff J. G. 1992 Amino acid substitution matrices from protein blocks. Proc. Natl. Acad. Sci. USA 89, 10915–10919.
Ho C. C., Tai S. M., Lee E. C., Mak T. S., Liu T. K., Tang V. W. et al. 2017 Rapid identification of pathogenic variants in two cases of charcot-marie-tooth disease by gene-panel sequencing. Int. J. Mol. Sci. 18.
Kircher M., Witten D. M., Jain P., O’Roak B. J., Cooper G. M. and Shendure J. 2014 A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315.
Kostera-Pruszczyk A., Kosinska J., Pollak A., Stawinski P., Walczak A., Wasilewska K. et al. 2014 Exome sequencing reveals mutations in MFN2 and GDAP1 in severe Charcot-Marie-Tooth disease. J. Peripher. Nerv. Syst. 19, 242–245.
Liu X., Jian X. and Boerwinkle E. 2011 dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Hum. Mutat. 32, 894–899.
Parman Y., Battaloglu E., Baris I., Bilir B., Poyraz M., Bissar-Tadmouri N. et al. 2004 Clinicopathological and genetic study of early-onset demyelinating neuropathy. Brain 127, 2540–2550.
Patzko A. and Shy M. E. 2012 Charcot-Marie-Tooth disease and related genetic neuropathies. Continuum (minneap Minn). 18, 39–59.
Pla-Martin D., Calpena E., Lupo V., Marquez C., Rivas E., Sivera R. et al. 2015 Junctophilin-1 is a modifier gene of GDAP1-related Charcot-Marie-Tooth disease. Hum. Mol. Genet. 24, 213–229.
Rossor A. M., Polke J. M., Houlden H. and Reilly M. M. 2013 Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat. Rev. Neurol. 9, 562–571.
Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J. et al. 2015 Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424.
Reilly M. M., Pareyson D., Burns J., Laura M., Shy M. E., Singh D. et al. 2017 221st ENMC International Workshop: Foot Surgery in Charcot-Marie-Tooth disease. 10–12 June 2016, Naarden, The Netherlands. Neuromuscul. Disord. 27, 1138–1142.
Rentzsch P., Witten D., Cooper G. M., Shendure J. and Kircher M. 2019 CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, 886–894.
Saporta M. A. 2014 Charcot-Marie-Tooth disease and other inherited neuropathies. Continuum (Minneap Minn). Peripher. Nerv. Syst. Disorders 20, 1208–1225.
Tazir M., Bellatache M., Nouioua S. and Vallat J. M. 2013 Autosomal recessive Charcot-Marie-Tooth disease: from genes to phenotypes. J. Peripher. Nerv. Syst. 18, 113–129.
Tazir M., Hamadouche T., Nouioua S., Mathis S. and Vallat J. M. 2014 Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update. J. Neurol. Sci. 347, 14–22.
Vallat J. M., Tazir M., Magy L., Le Masson G. and Mathis S. 2018 The classification of Charcot-Marie-Tooth diseases, a never-ending story: CMT4? Brain 141, e70.
Acknowledgements
We thank all family members for their cooperation. This study was supported by Shanxi Scholarship Council of China Certificate of Studying Abroad (no. 20171702), Fund Programme for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province (no. 201919) and the National Population and Reproductive Health Science Data Center, China (no. 2005DKA32408).
Author information
Authors and Affiliations
Corresponding author
Additional information
Corresponding editor: Analabha Basu
Rights and permissions
About this article
Cite this article
XUE, H., MAKSEMOUS, N., SIDHOM, D. et al. Novel compound heterozygous missense mutations in GDAP1 cause Charcot–Marie–Tooth type 4A. J Genet 100, 58 (2021). https://doi.org/10.1007/s12041-021-01307-0
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12041-021-01307-0